A detailed history of Valeo Financial Advisors, LLC transactions in Shockwave Medical, Inc. stock. As of the latest transaction made, Valeo Financial Advisors, LLC holds 928 shares of SWAV stock, worth $0. This represents 0.01% of its overall portfolio holdings.

Number of Shares
928
Previous 1,728 46.3%
Holding current value
$0
Previous $562,000 46.26%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$191.17 - $325.63 $152,936 - $260,504
-800 Reduced 46.3%
928 $302,000
Q1 2024

Apr 19, 2024

BUY
$191.17 - $325.63 $38,234 - $65,126
200 Added 13.09%
1,728 $562,000
Q4 2023

Jan 29, 2024

BUY
$160.99 - $215.69 $245,992 - $329,574
1,528 New
1,528 $291,000
Q2 2023

Jul 14, 2023

SELL
$223.05 - $302.68 $38,810 - $52,666
-174 Reduced 17.99%
793 $226,000
Q1 2023

Apr 17, 2023

BUY
$175.41 - $217.92 $169,621 - $210,728
967 New
967 $209,000
Q2 2021

Jul 22, 2021

SELL
$131.45 - $201.49 $2,629 - $4,029
-20 Closed
0 $0
Q1 2021

Apr 12, 2021

SELL
$92.73 - $142.05 $185 - $284
-2 Reduced 9.09%
20 $3,000
Q3 2020

Oct 28, 2020

SELL
$42.79 - $75.8 $55,798 - $98,843
-1,304 Reduced 98.34%
22 $2,000
Q2 2020

Jul 20, 2020

BUY
$27.25 - $47.53 $20,328 - $35,457
746 Added 128.62%
1,326 $63,000
Q1 2020

Apr 13, 2020

BUY
$23.16 - $47.74 $12,876 - $26,543
556 Added 2316.67%
580 $21,000
Q4 2019

Jan 24, 2020

SELL
$29.4 - $44.98 $14,700 - $22,490
-500 Reduced 95.42%
24 $1,000
Q3 2019

Oct 15, 2019

BUY
$29.71 - $55.23 $14,855 - $27,615
500 Added 2083.33%
524 $16,000
Q2 2019

Jul 10, 2019

BUY
$29.73 - $66.02 $713 - $1,584
24 New
24 $1,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Valeo Financial Advisors, LLC Portfolio

Follow Valeo Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.